Vera Therapeutics, Inc.

NASDAQ:VERA

Biotechnology

Healthcare
$26.75 +0.27%

+$0.09 today

Market cap
$1.93B
Beta
0.95
P/E (TTM)
-6.8
EPS (TTM)
-$5.16
52W Low $19.07High $56.05

Volume 1.05M

Average 1.18M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$315.47M

FY 2025 · Annual

Net Income

-$299.62M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0(846K)000
Gross Profit0846K000
Gross Margin—————
Research & Development22.48M69.84M78.23M126.17M215.26M
Selling, General & Admin11.92M21.91M23.79M41M100.22M
Operating Expenses34.4M91.75M102.01M167.17M315.47M
Depreciation & Amortization176K(846K)21K105K468K
EBITDA(32.41M)(88.91M)(92.18M)(144.42M)(291.62M)
EBITDA Margin—————
Operating Income(34.4M)(90.9M)(102.01M)(167.17M)(315.47M)
Operating Margin—————
Interest Income15K1.75M7.98M20.71M24.48M
Interest Expense20K992K3.79M7.63M7.53M
Other Income / Expenses1.79M1.85M6.02M15.02M15.86M
Income Before Tax(32.61M)(89.06M)(95.99M)(152.15M)(299.61M)
Pre-Tax Margin—————
Income Tax Expense1K1K1K1K1K
Net Income(32.61M)(89.06M)(95.99M)(152.15M)(299.62M)
Net Margin—————
EPS (Basic)(2.43)(3.35)(2.25)(2.75)(4.66)
EPS (Diluted)(2.43)(3.35)(2.25)(2.75)(4.66)
Weighted Avg Shares13.44M26.57M42.71M55.33M64.23M
Weighted Avg Shares (Diluted)13.44M26.57M42.71M55.33M64.23M

VERA Earnings Waterfall · TTM

NASDAQ:VERA · Revenue to Net Income

Key Ratios

EPS$-5.86
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-7.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$401.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-5.86, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
8-KCurrent reportSep 15, 2026

How much revenue does VERA generate?

Vera Therapeutics, Inc. (VERA) reported $0.00 of revenue in fiscal 2025.

Is VERA profitable?

Vera Therapeutics, Inc. (VERA) reported -$299.62M of net income.